NATCAPSUQ Announces Q2 & H1FY26 Results
Natural Capsules Limited (NATCAPSUQ) declared Q2 & H1FY26 results. Revenue for Q2FY26 was ₹45.80 crore & H1FY26 was ₹91.01 crore. The company faced challenges due to US tariffs and technical issues in API production.
The financial results indicate a moderate impact due to challenges faced by the company, but they are taking steps to mitigate these challenges.
The announcement discusses both positive aspects (stable capsule business) and negative aspects (tariffs, technical difficulties).
* Natural Capsules Limited (NCL) announced its financial results for the quarter and half year ended 30th September 2025. * Q2FY26 revenue was ₹45.80 crore, EBITDA was ₹0.88 crore, and PAT was ₹6.99 crore. * H1FY26 revenue was ₹91.01 crore, EBITDA was ₹0.57 crore, and PAT was ₹12.57 crore. * The company faced challenges due to tariffs imposed on Indian exports to the US, affecting demand in the US market. * Technical difficulties in scaling up fermentation batches for API production have also caused delays. * The company expects to commission the new HPMC production line by the end of the quarter. * Mr. Sunil Mundra, Executive Director, mentioned that Q2FY26 was a stable quarter for the capsules business, but growth triggers were affected by US tariffs. He remains confident in overcoming challenges and delivering better performance in the future.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.